Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, won a court order banning generic versions of the attention-deficit treatment Strattera until a patent appeal is decided. The U.S.

Indianapolis-based Eli Lilly and Co. is suing Sun Pharmaceutical Industries Ltd. of India to stop Sun from selling a generic version of its hyper-disorder drug Strattera. Lilly, which filed the suit ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Strattera (atomoxetine, Eli Lilly) to treat children and adults with attention ...

NEW YORK, Aug 27 (Reuters) - A federal appeals court has extended a temporary order blocking 10 companies from selling generic versions of Eli Lilly and Co's Strattera attention deficit disorder drug.

Strattera 40 mg pills generic — overnight cheap online. Qualitative and quantitative composition Each hard capsule contains atomoxetine hydrochloride equivalent to 10mg, 18mg, 25mg, 40mg, 60mg, 80mg ...

Eli Lilly & Co.’s Strattera faces generic competition after the drugmaker lost a U.S. court case over the attention-deficit treatment, its second patent ruling setback in a month. U.S. District Judge ...

FDA approves generic forms of Strattera The generic forms of Strattera are the first to be approved by the FDA for the treatment of ADHD. The US Food and Drug Administration (FDA) has approved the ...

NEW YORK, Aug 16 (Reuters) - Eli Lilly and Co asked a federal judge on Monday to temporarily block sales of generic versions of its Strattera attention deficit disorder drug while it appeals a ruling ...

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera , atomoxetine ...

(CN) - The Federal Circuit extended an order temporarily blocking generic versions of Eli Lilly & Co.'s Strattera while the pharmaceutical giant appeals a ruling invalidating its U.S. patent for the ...